May 18 2022 — Older breast cancer survivors with cardiometabolic risk factors who restricted food intake to eight hours ...
May 18, 2022 — Continuous monitoring with an insertable cardiac monitor (ICM) is shown to be more successful in ...
May 18, 2022 — For the third straight year, Henry Ford Hospital interventional cardiologist Khaldoon Alaswad, M.D. will ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 17, 2022 — Results of a new study reveal Black patients hospitalized with atrial fibrillation (AF) are under ...
May 17, 2022 — Results from a new study show success of intended same day discharge (SDD) improves over time for ...
May 17, 2022 — Heart Rhythm 2022 has come to a close, and the Heart Rhythm Society has released some stats regarding ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 17, 2022 — Amarin Corporation plc announced that research on the potential population health impact and cost ...
May 17, 2022 — On the heels of its landmark valvular heart disease (VHD) prevalence abstract published in Journal of the ...
May 16, 2022 — Philips, a global leader in health technology, announced at EuroPCR (17 - 20 May 2022, Paris, France) the ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 16, 2022 — Boston Scientific announced that Peter M. “Pete” Nicholas, co-founder and former CEO of Boston Scientific ...
May 16, 2022 — The Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS) and ...
May 16, 2022 — A new report by a team of cardiologists from the Heart & Vascular Hospital, Hackensack Meridian ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
May 16, 2022 — Right heart failure (RHF) continues to be a major source of morbidity and mortality following left ...
May 16, 2022 — The Cardiovascular Research Foundation (CRF) announced that TVT: The Structural Heart Summit will feature ...
May 13, 2022 — Bristol Myers Squibb’s mavacamten will stand rather unchallenged in the hypertrophic cardiomyopathy (HCM) ...